From: Effect of immunology biomarkers associated with hip fracture and fracture risk in older adults
 | Full sample (n = 40) | Fracture group (n = 20) | Non-fracture group (n = 20) | P value* |
---|---|---|---|---|
Demographic | Â | Â | Â | Â |
Age, years | 81.23 (8.23) | 87.25 (6.73) | 75.20 (4.15) | 0.026 |
Sex (men/female), n (%) | 11 (27.5)/29 (72.5) | 4 (20)/16 (80) | 7 (35)/13 (65) | 0.480 |
BMI (kg/m2)a | 27.39 (4.72) | 24.91 (2.74) | 29.87 (5.02) | 0.003 |
Clinical status | ||||
CIRS-G score | 11.45 (4.21) | 12.7 (4.81) | 10.2 (3.17) | 0.060 |
Polypharmacy score | 6.28 (3.16) | 7.25 (3.09) | 5.3 (3) | 0.534 |
Osteoporosis (n, %) | 10 (25%) | 4 (20%) | 6 (30%) | 0.716 |
Functional status | ||||
Barthel Index (ADL), scorec | 81.63 (26.13) | 67.5 (30.41) | 95.75 (7.48) | < 0.001 |
Functional Ambulation Category (n, %) | Â | Â | ||
FAC 0 to 1 | 3 (7.5%) | 3 (15%) | 0 (0) | 0.032 |
FAC 4 to 5 | 36 (92.5%) | 17 (85%) | 20 (100%) | |
Frailty scored | 2.18 (1.69) | 3.05 (1.47) | 1.3 (1.42) | < 0.001 |
Hand grip strength (Kg) | 17.63 (9.8) | 11.3 (6.24) | 23.95 (8.6) | < 0.001 |
MNA scoree | 23.43 (6.51) | 18.83 (6.08) | 28.03 (2.33) | < 0.001 |
Pfeiffer’s SPMSQf | 2.55 (3.80) | 5.05 (4.05) | 0.5 (0.224) | < 0.001 |
Depression score (n, %)g | 8 (20%) | 6 (42.9%) | 2 (10%) | 0.026 |
FRAX mayor scoreh | 9.76 (7,15) | 13.4 (6.99) | 6.12 (5.29) | < 0.001 |
FRAX hip scorei | 4.43 (3.85) | 6.29 (3.79) | 2.58 (2.94) | < 0.001 |
Bone mineral density and body composition | ||||
BMDj - total hip | 0.873 (0.186) | 0.735 (0.079) | 0.976 (0.177) | 0.001 |
BMD – femoral neck | 0.869 (0.211) | 0.739 (0.119) | 0.966 (0.217) | 0.011 |
BMD – lumbar spine | 1.153 (0.256) | 0.981 (0.18) | 1.239 (0.247) | 0.007 |
BMD – foreman | 0.768 (0.314) | 0.679 (0.127) | 0.812 (0.37) | 0.281 |
ASMIk | 6.24 (1.63) | 5.06 (1.27) | 7.43 (0.95) | < 0.001 |
ASM/BMIl | 0.607 (0.188) | 0.526 (0.155) | 0.687 (0.187) | 0.005 |